Entrepreneur Scott M. Rocklage Ph.D gave an interview with IdeaMensch and explains his success. Dr. Rocklage empathizes the idea of ‘measured risk-taking’ and elaborates on how to go about it with a positive outlook on business growth and choices.
He talks about his failures and how he overcame them. Dr. Rocklage’s advice is backed up by an impressive resume and it proves his advice is rock solid.
One of Dr. Rocklage’s current endeavors is 5AM Ventures. As a leading capital investment firm 5AM Ventures investing in budding life science companies.
The firm offers high returns with low risks to investors. It nurtures health care involved in cutting-edge science and breakthroughs in medical fields of cancer research and other serious medical conditions. The firm offers it’s scientific, medical, operational, legal and financial expertise to up and coming research organizations.
Dr. Rocklage states in his interview how he works with doctors and scientists to bring their ideas to life and present them to the world in need of solutions. He is specifically interested in the amazing growth happening now with mutations and genotypes as unique cancer treatments. He goes on to explain how these solutions are already saving lives and he expects greater developments in the near future.
The one thing he would do different Dr. Rocklage says is focusing more on people and the team selections. He also advises controlling your own future is more important than working for companies in the Fortune 500. Know your strengths, stick to them and to not always take the easy road to success are methods the Doctor believes in to pave a healthy road to success.
Dr. Rocklage says his failures came from choosing the wrong people in areas of management and he advises quick action on changing the personnel is the way to correct that mistake. Keep your eye on performance and he advises do not wait for evaluations and reviews.
Scott Rocklage Ph.D is a graduate of MIT and the University of California with degrees in chemistry. He holds over 30 US patents and has over 100 publications with peer reviews.